Suchergebnisse - "Flack, John M."

BASELINE CHARACTERISTICS OF PATIENTS IN BAXHTN: A PHASE 3 TRIAL OF THE ALDOSTERONE SYNTHASE INHIBITOR BAXDROSTAT IN PATIENTS WITH UNCONTROLLED OR RESISTANT HYPERTENSION.

Autoren: Flack, John M. Azizi, Michel Brown, Jenifer M. et al.

Quelle: Journal of Hypertension; 2025 Supplement1, Vol. 43, pe112-e113, 2p

The Authors Reply, 'as‐needed intravenous antihypertensive therapy and blood pressure control'

Autoren: Flack, John M. Moser, Lynette R. Lipari, Melissa et al.

Quelle: Journal of Hospital Medicine. 11:526-526

Schlagwörter: Medicine (General), 03 medical and health sciences, 0302 clinical medicine, Health Sciences, Hypertension, Humans, Administration, Intravenous, Blood Pressure, Antihypertensive Agents, 3. Good health

Dateibeschreibung: application/pdf

Zugangs-URL: http://deepblue.lib.umich.edu/bitstream/2027.42/122423/2/jhm2565.pdf
https://pubmed.ncbi.nlm.nih.gov/26918782
http://europepmc.org/abstract/MED/26918782
https://www.ncbi.nlm.nih.gov/pubmed/26918782
https://core.ac.uk/display/86637972
https://onlinelibrary.wiley.com/doi/full/10.1002/jhm.2565
https://www.onlinelibrary.wiley.com/doi/pdf/10.1002/jhm.2565

Aprocitentan for Blood Pressure Reduction in Black Patients.

Autoren: Flack, John M. Schlaich, Markus P. Weber, Michael A. et al.

Quelle: Hypertension (0194911X); Apr2025, Vol. 82 Issue 4, p601-610, 10p

Expanding the Search for Primary Aldosteronism in Clinical Settings.

Autoren: Flack, John M. Buhnerkempe, Michael G. Jennings, Garry L.R.

Quelle: Hypertension (0194911X); Oct2025, Vol. 82 Issue 10, p1548-1550, 3p

Blood Pressure–Elevating and Antihypertensive Medication Prescription Trends.

Autoren: Kumar, Ashutosh Therrien, Nicole L. Ogwuegbu, John I. et al.

Quelle: Hypertension (0194911X); Jun2025, Vol. 82 Issue 6, p1106-1115, 10p

Does Vitamin D Provide Added Benefit to Antihypertensive Therapy in Reducing Left Ventricular Hypertrophy Determined by Cardiac Magnetic Resonance?

Autoren: Levy, Phillip D Twiner, Michael J Brody, Aaron M et al.

Quelle: American Journal of Hypertension; Jan2023, Vol. 36 Issue 1, p50-62, 13p

Schlagwörter: CARDIAC magnetic resonance imaging, LEFT ventricular hypertrophy, CARDIAC hypertrophy, VITAMIN D deficiency, CHOLECALCIFEROL

Sacubitril/Valsartan as an Effective Hypertension Treatment Option in Those With Chronic Type B Aortic Dissection.

Autoren: Buhnerkempe, Michael G Bitner, Stephanie Flack, John M

Quelle: American Journal of Hypertension; Aug2024, Vol. 37 Issue 8, p543-545, 3p

Schlagwörter: AORTIC dissection, VALSARTAN, ENTRESTO, HYPERTENSION

Evolving the Role of Black Race in Hypertension Therapeutics.

Autoren: Flack, John M Bitner, Stephanie Buhnerkempe, Michael

Quelle: American Journal of Hypertension; Oct2024, Vol. 37 Issue 10, p739-744, 6p

Schlagwörter: COMBINATION drug therapy, BLACK people, ACE inhibitors, DRUG therapy, ANGIOTENSIN-receptor blockers

Recruitment, Retention, and Future Direction for a Heart Health Education and Risk Reduction Intervention Led by Community Health Workers in an African American Majority City.

Autoren: Gleason-Comstock, Julie Calhoun, Cindy Bolden Mozeb, Ghadir et al.

Quelle: Journal of Racial & Ethnic Health Disparities; Jun2023, Vol. 10 Issue 3, p1432-1440, 9p

The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association.

Autoren: Bress, Adam P. Anderson, Timothy S. Flack, John M. et al.

Quelle: Hypertension (0194911X); Aug2024, Vol. 81 Issue 8, pe94-e106, 13p

Resistant Hypertension: Disease Burden and Emerging Treatment Options.

Autoren: Flack, John M. Buhnerkempe, Michael G. Moore, Kenneth Todd

Quelle: Current Hypertension Reports; May2024, Vol. 26 Issue 5, p183-199, 17p

Does Vitamin D Provide Added Benefit to Antihypertensive Therapy in Reducing Left Ventricular Hypertrophy Determined by Cardiac Magnetic Resonance?

Autoren: Levy, Phillip D Twiner, Michael J Brody, Aaron M et al.

Weitere Verfasser: Levy, Phillip D Twiner, Michael J Brody, Aaron M et al.

Quelle: American Journal of Hypertension ; volume 36, issue 1, page 50-62 ; ISSN 0895-7061 1941-7225

Verfügbarkeit: https://doi.org/10.1093/ajh/hpac096
https://academic.oup.com/ajh/advance-article-pdf/doi/10.1093/ajh/hpac096/47162615/hpac096.pdf
https://academic.oup.com/ajh/article-pdf/36/1/50/48423433/hpac096.pdf

ACC/AHA and ESC/ESH Hypertension Guidelines: Contrasting Versions of Idiosyncratic Excellence.

Autoren: Flack, John M Calhoun, David

Quelle: American Journal of Hypertension; Aug2019, Vol. 32 Issue 8, p705-708, 4p

Schlagwörter: HYPERTENSION, COMBINATION drug therapy, GUIDELINES, ANKLE brachial index

Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association.

Autoren: Juraschek, Stephen P. Cortez, Melissa M. Flack, John M. et al.

Quelle: Hypertension (0194911X); Mar2024, Vol. 81 Issue 3, pe16-e30, 15p

The Role of Therapeutic Inertia and the Use of Fixed-Dose Combination Therapy in the Management of Hypertension.

Autoren: Basile, Jan Black, Henry R. Flack, John M. et al.

Quelle: Journal of Clinical Hypertension; Aug2007, Vol. 9 Issue 8, p636-645, 10p

Authors.

Quelle: Academic Emergency Medicine; May2011 Supplement, Vol. 18, pS259-S268, 10p

Schlagwörter: AUTHORS, EMERGENCY medicine

Editors' Commentary on the 2023 ESH Management of Arterial Hypertension Guidelines.

Autoren: Whelton, Paul K. Flack, John M. Jennings, Garry et al.

Quelle: Hypertension (0194911X); Sep2023, Vol. 80 Issue 9, p1795-1799, 5p

Clinical Outcomes in Hypertensive Emergency: A Systematic Review and Meta-Analysis.

Autoren: Siddiqi, Tariq Jamal Usman, Muhammad Shariq Rashid, Ahmed Mustafa et al.

Quelle: Journal of the American Heart Association; 7/18/2023, Vol. 12 Issue 14, p1-10, 30p

Effect of Lower Blood Pressure Goals on Left Ventricular Structure and Function in Patients With Subclinical Hypertensive Heart Disease.

Autoren: Levy, Phillip D Burla, Michael J Twiner, Michael J et al.

Quelle: American Journal of Hypertension; Sep2020, Vol. 33 Issue 9, p837-845, 9p

Schlagwörter: HYPOTENSION, HEART diseases, HYPERTENSION, CLINICAL trial registries, BLOOD pressure

Serious Adverse Events Cluster in Participants Experiencing the Primary Composite Cardiovascular Endpoint: A Post Hoc Analysis of the SPRINT Trial.

Autoren: Botchway, Albert Buhnerkempe, Michael G Prakash, Vivek et al.

Quelle: American Journal of Hypertension; Jun2020, Vol. 33 Issue 6, p528-533, 6p

Schlagwörter: ADVERSE health care events, ACUTE coronary syndrome, MYOCARDIAL infarction